0001179110-19-002638.txt : 20190226 0001179110-19-002638.hdr.sgml : 20190226 20190226170623 ACCESSION NUMBER: 0001179110-19-002638 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190222 FILED AS OF DATE: 20190226 DATE AS OF CHANGE: 20190226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CAPEK JOHN M CENTRAL INDEX KEY: 0001328034 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 19634379 MAIL ADDRESS: STREET 1: 111 MONUMENT CIRCLE, SUITE 2900 CITY: INDIANAPOLIS STATE: IN ZIP: 46204-5129 FORMER NAME: FORMER CONFORMED NAME: Capek John M DATE OF NAME CHANGE: 20050523 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 edgar.xml FORM 4 - X0306 4 2019-02-22 0 0000001800 ABBOTT LABORATORIES ABT 0001328034 CAPEK JOHN M 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6400 0 1 0 0 Executive Vice President Common shares without par value 2019-02-22 4 A 0 19367 00 A 317667 D Option (right to buy) 75.90 2019-02-22 4 A 0 101519 0 A 2020-02-22 2029-02-21 Common shares 101519 101519 D These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 33,839 on February 22, 2020, 33,840 on February 22, 2021, and 33,840 on February 22, 2022. Jessica H. Paik, by power of attorney for John M. Capek 2019-02-26 EX-24 2 ex24capek.txt Exhibit 24.1 POWER OF ATTORNEY The undersigned constitutes and appoints HUBERT L. ALLEN, JESSICA H. PAIK, and AARON N. RICE, and each of them individually, as the undersigned's true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for the undersigned and in the undersigned's name, place and stead, to prepare and sign any and all Securities and Exchange Commission ("SEC") Notices of Proposed Sales of Securities pursuant to Rule 144 under the Securities Act of 1933 on Form 144, all SEC statements on Forms 3, 4 and 5 as required under Section 16(a) of the Securities Exchange Act of 1934, including a Form ID and any other documents necessary to obtain codes and passwords necessary to make electronic filings, and any amendments to such forms, and to file the same with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite, necessary or desirable to be done under said Rule 144 and Section 16(a), as fully for all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent may lawfully do or cause to be done by virtue hereof. A copy of this power of attorney shall be filed with the SEC. The authorization set forth above shall continue in full force and effect until the undersigned is no longer required to file Forms 144, 3, 4, or 5 or if earlier, until the undersigned revokes such authorization by written instructions to the attorney-in-fact. Date: December 14, 2018 /s/ John M. Capek Signature of Reporting Person John M. Capek Abbott Laboratories 100 Abbott Park Road Abbott Park, IL 60064